Literature DB >> 15834894

Developmental toxicity research of ginsenoside Rb1 using a whole mouse embryo culture model.

Peng Liu1, Yajun Xu, Huijun Yin, Junbo Wang, Keji Chen, Yong Li.   

Abstract

BACKGROUND: Ginseng has been widely used around the world for many years. Knowledge is limited, however, on its effects on embryonic development.
METHODS: Whole embryo culture was used to explore the developmental toxicity of ginsenoside Rb1 (GRb1) on mouse embryos. All embryos were exposed to different concentrations of GRb1, and scored for their growth and differentiation at the end of the 48-hr culture period.
RESULTS: Total morphological score decreased significantly at the concentration of GRb1 of 30 microg/ml and was further reduced at 50 microg/ml. Yolk sac was affected at the lower concentration of 15 microg/ml. Developments of midbrain, forebrain, and optic system were relatively sensitive to GRb1 and were affected at the concentration of 30 microg/ml. Allantois, flexion, branchial arch, and limb buds were affected at 50 microg/ml. At this concentration, the embryonic crown-rump length, head length, and somite number were also reduced significantly compared to the control group.
CONCLUSIONS: These results suggest that GRb1 has teratogenic effect during the mouse organogenetic period. We suggest that before more data in humans is available, ginseng should be used with caution by pregnant women in the first trimester.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834894     DOI: 10.1002/bdrb.20038

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN: 1542-9733


  10 in total

Review 1.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 2.  Review of cases of patient risk associated with ginseng abuse and misuse.

Authors:  Doo Jin Paik; Chang Ho Lee
Journal:  J Ginseng Res       Date:  2014-12-06       Impact factor: 6.060

3.  Effects of multivitamins and known teratogens on chick cardiomyocytes micromass culture assay.

Authors:  Samreen Memon; Margaret Pratten
Journal:  Iran J Basic Med Sci       Date:  2013-09       Impact factor: 2.699

Review 4.  American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties.

Authors:  Daria Szczuka; Adriana Nowak; Małgorzata Zakłos-Szyda; Ewa Kochan; Grażyna Szymańska; Ilona Motyl; Janusz Blasiak
Journal:  Nutrients       Date:  2019-05-09       Impact factor: 5.717

5.  Developmental and reproductive toxicity assessment in rats with KGC-HJ3, Korean Red Ginseng with Angelica gigas and Deer antlers.

Authors:  Jinsoo Lee; Ji-Seong Jeong; Kyung-Jin Cho; Kyeong-Nang Moon; Sang Yun Kim; Byungcheol Han; Yong-Soon Kim; Eun Ju Jeong; Moon-Koo Chung; Wook-Joon Yu
Journal:  J Ginseng Res       Date:  2018-01-10       Impact factor: 6.060

Review 6.  Panax ginseng and Panax quinquefolius: From pharmacology to toxicology.

Authors:  Cesare Mancuso; Rosaria Santangelo
Journal:  Food Chem Toxicol       Date:  2017-07-08       Impact factor: 6.023

Review 7.  Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells.

Authors:  Fang He; Changyin Yu; Tao Liu; Huilin Jia
Journal:  Front Pharmacol       Date:  2020-01-23       Impact factor: 5.810

Review 8.  Toxicity as prime selection criterion among SARS-active herbal medications.

Authors:  Franz Oesch; Barbara Oesch-Bartlomowicz; Thomas Efferth
Journal:  Phytomedicine       Date:  2021-01-28       Impact factor: 5.340

9.  Diversity and composition of the Panax ginseng rhizosphere microbiome in various cultivation modesand ages.

Authors:  Ai-Zi Tong; Wei Liu; Qiang Liu; Guang-Qing Xia; Jun-Yi Zhu
Journal:  BMC Microbiol       Date:  2021-01-08       Impact factor: 3.605

Review 10.  Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.

Authors:  Zhihan Chen; Jingping Wu; Sijing Li; Caijiao Liu; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.